Shilpa Medicare Limited — Updates, 24-02-2026: Press Release
24-02-2026 | 10:43 am
24-02-2026 | 10:43 am
Shilpa Medicare's subsidiary, Shilpa Biologicals, partnered with SteinCares for exclusive rights to commercialize a biosimilar across Latin America. This marks SBPL's entry into the region, leveraging its manufacturing expertise for expanded market access.
No comments yet. Be the first to comment!
